GX

DRUG2 trials

Sponsors

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Tianjin Medical University Cancer Institute and Hospital

Conditions

Pancreatic Cancer

Phase 2

Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

RecruitingNCT06389760

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPancreatic Cancer

Start: 2023-10-18End: 2026-09-30Target: 57Updated: 2024-10-31

Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Not yet recruitingNCT06409429

Tianjin Medical University Cancer Institute and HospitalPancreatic Cancer

Start: 2024-05-01End: 2027-05-30Target: 146Updated: 2024-05-10